Processing

Please wait...

Settings

Settings

1. WO2000041729 - REMEDIES FOR CORNEAL DISORDERS

Publication Number WO/2000/041729
Publication Date 20.07.2000
International Application No. PCT/JP2000/000095
International Filing Date 12.01.2000
Chapter 2 Demand Filed 12.04.2000
IPC
A61K 31/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61K 31/661 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
66Phosphorus compounds
661Phosphorus acids or esters thereof not having P-C bonds, e.g. fosfosal, dichlorvos, malathion
CPC
A61K 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61K 31/661
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
66Phosphorus compounds
661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion ; or mevinphos
Applicants
  • SANTEN PHARMACEUTICAL CO., LTD. [JP/JP]; 9-19, Shimoshinjo 3-chome Higashiyodogawa-ku Osaka-shi Osaka 533-8651, JP (AllExceptUS)
  • NISHIDA, Teruo [JP/JP]; JP
  • NAKATA, Katsuhiko [JP/JP]; JP (UsOnly)
  • NAKAMURA, Masatsugu [JP/JP]; JP (UsOnly)
Inventors
  • NISHIDA, Teruo; JP
  • NAKATA, Katsuhiko; JP
  • NAKAMURA, Masatsugu; JP
Agents
  • KISHIMOTO, Einosuke ; Inaba Building, 3rd Floor 13-18, Nishishinsaibashi 1-chome Chuo-ku Osaka-shi Osaka 542-0086, JP
Priority Data
11/542012.01.1999JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) REMEDIES FOR CORNEAL DISORDERS
(FR) MEDICAMENTS CONTRE LES TROUBLES DE LA CORNEE
Abstract
(EN)
Remedies for corneal disorders which contain as the active ingredient compounds having an effect of activating Rho (for example, corneal epithelium extension promoters). The compounds having the effect of activating Rho are exemplified by lysophatidic acid and acyl derivatives thereof. The corneal disorders are exemplified by a corneal ulcer, corneal epithelium scraping, corneitis and dry eye.
(FR)
La présente invention concerne des médicaments qui contiennent en tant qu'ingrédient actif des composés dont l'effet est d'activer Rho (par exemple, les promoteurs d'extension de l'épithélium cornéen). Les composés dont l'effet est d'activer Rho sont, à titre d'exemple représentatif, l'acide lysophatidique et ses dérivés acyle. Les troubles de la cornée concernés comprennent entre autres l'ulcère de la cornée, la lésion épithéliale de la cornée, la kératite et le syndrome de l'oeil sec.
Also published as
US09869949
Latest bibliographic data on file with the International Bureau